Preclinical safety assessment has traditionally relied on animal studies to identify potential toxicities and guide first‑in‑human dosing decisions. Read the full blog at BioIVT.
Human biospecimens are essential for preclinical research, but their value goes beyond their biological origin. Sample handling, storage, and transport impacts on their quality and, therefore, on the reliability [...]
Human biospecimens are a critical input for preclinical research, but their scientific value is highly dependent on how they are handled throughout their lifecycle. Variability introduced during collection, processing, [...]
Cryopreserved primary human liver cells offer a practical balance between biological relevance and operational efficiency. When handled correctly, cryopreserved hepatocytes and non-parenchymal cells (NPCs) retain key metabolic, transporter, and [...]
22% of clinical trials fail due to hepatotoxicity, and the number rises to 32% when talking about market withdrawals. These figures highlight a persistent gap in our ability to [...]
What Are Liver Non‑Parenchymal Cells and How Do They Differ from Hepatocytes? Liver non-parenchymal cells (NPCs) are a heterogeneous group of cells that form the non-hepatocyte component of the [...]
Parc Científic de Barcelona (PCB), Tower I, Baldiri Reixac 4-8, 08028 Barcelona, Spain
Cytes Biotechnologies S.L. within the framework of the Export Initiation Program of ICEX, has had the support of ICEX and with the co-financing of the European FEDER fund. The purpose of this support is to contribute to the international development of the company and its environment.
Privacy Policy | Terms and Conditions | Data Protection Policy | Cookies Policy | All Right Reserved Copyright © 2026
